OYST
Oyster Point Pharma, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Jeffrey Nau
IPO Date
2019-10-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Oyster Point Pharma, Inc.
CEO
Jeffrey Nau
IPO Date
2019-10-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 1,850,818 |
| $0.00 |
| 4 Jan 2023 | New Enterprise Associates 14, L.P. | director | U-Tender | Disposed | 5,925,287 | $0.00 |
| 4 Jan 2023 | New Enterprise Associates 14, L.P. | 10 percent owner | U-Tender | Disposed | 5,925,287 | $11.00 |
| 4 Jan 2023 | Nau Jeffrey | President and CEO | F-InKind | Disposed | 2,607 | $11.70 |
| 4 Jan 2023 | Nau Jeffrey | President and CEO | U-Tender | Disposed | 100,738 | $0.00 |
| 4 Jan 2023 | Nau Jeffrey | President and CEO | D-Return | Disposed | 210,000 | $0.00 |
| 4 Jan 2023 | Lochner Daniel | Chief Financial Officer | F-InKind | Disposed | 938 | $11.70 |
| 4 Jan 2023 | Lochner Daniel | Chief Financial Officer | U-Tender | Disposed | 56,289 | $0.00 |
| 4 Jan 2023 | Lochner Daniel | Chief Financial Officer | D-Return | Disposed | 87,900 | $0.00 |